Advanced Biomed Inc.
ADVB
$5.10
$0.357.37%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 276.60K | 210.30K | 287.90K | 978.30K | 347.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 519.80K | 396.60K | 523.90K | 1.21M | 567.50K |
| Operating Income | -519.80K | -396.60K | -523.90K | -1.21M | -567.50K |
| Income Before Tax | -488.90K | 7.00M | -386.90K | -701.60K | -1.20M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -488.90K | 7.00M | -386.90K | -701.60K | -1.20M |
| Earnings from Discontinued Operations | -- | -144.30K | -- | -- | -186.40K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -488.90K | 6.86M | -386.90K | -701.60K | -1.38M |
| EBIT | -519.80K | -396.60K | -523.90K | -1.21M | -567.50K |
| EBITDA | -510.50K | -379.10K | -475.90K | -1.15M | -545.00K |
| EPS Basic | -0.38 | 6.34 | -0.36 | -0.65 | -1.35 |
| Normalized Basic EPS | -0.24 | -0.20 | -0.22 | -0.41 | -0.73 |
| EPS Diluted | -0.38 | 6.34 | -0.36 | -0.65 | -1.35 |
| Normalized Diluted EPS | -0.24 | -0.20 | -0.22 | -0.41 | -0.73 |
| Average Basic Shares Outstanding | 1.28M | 1.08M | 1.08M | 1.08M | 1.02M |
| Average Diluted Shares Outstanding | 1.28M | 1.08M | 1.08M | 1.08M | 1.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |